Finch Therapeutics Group, Inc. (FNCH) Financials

FNCH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2024 45.6 million 31.4 million
March 31, 2024 50.1 million 31.1 million
Dec. 31, 2023 71.0 million 48.1 million
Sept. 30, 2023 59.5 million 33.7 million

FNCH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2024 -4.7 million 15000
March 31, 2024 -4.4 million 28000
Dec. 31, 2023 -3.7 million 114000
Sept. 30, 2023 -5.3 million 335000

FNCH Net Income

No data available :(

FNCH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2024 16.0 million - 29.0 million
March 31, 2024 20.8 million - 29.6 million
Dec. 31, 2023 25.1 million 28.4 million 30.1 million
Sept. 30, 2023 28.8 million 28.8 million 30.8 million

FNCH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2024 ?
March 31, 2024 ?
Dec. 31, 2023 ?
Sept. 30, 2023 1.6 million

FNCH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2024 - - 6.1 million -
March 31, 2024 - - 5.1 million -43000
Dec. 31, 2023 14000 1.6 million 4.7 million -
Sept. 30, 2023 - - 3.7 million -

FNCH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2024 - 44000
March 31, 2024 - 43000
Dec. 31, 2023 2.8 million 44000
Sept. 30, 2023 - 52000

FNCH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

FNCH

Price: $10.20

52 week price:
2.00
16.10

Earnings Per Share: -8.80 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 136300

Market Capitalization: 14.8 million

Links: